参考文献
【1】McCarthy EJ.Malignant hyperthermia:pathophysiology,clinical presentation,and treatment[J].AACN Clin Issues,2004,15(2):231-237.
【2】Denborough MA,Forster JF,Lovell RR,et al.anaesthetic deaths in a family[J].Br J Anaesth,1962,34:395-396.
【3】Henry Rosenberg,Mark Davis,Danielle James,et al.Malignant hyperthermia[J].Orphanet Journal of Rare Diseases,2007, 2:21.
【4】Robinson RL, Curran JL, Ellis FR,et al.Multiple interacting gene products may influence susceptibility to malignant hyperthermia[J].Annals of Human Genetics,2011,64:307-320.
【5】Larach MC,Localio AR,Allen GC,et al,A clinical grading scale to predict malignant hyperthemia susceptibility[J].Anesthesiology,1994,80:771-779.
【6】Kozack JK,Machyre dl.Maligant hyperthemia[J].Phys Ther,2001,81(3):945-951.
【7】Hopkins PM.Maligant hyperthemia:advances in clinical management and diagnosis[J].Br J Anaesth,2000,85(1):118-128.
【8】Visoiu M,Young MC,Wieland K,et al.Anesthetic drugs and onset of malignant hyperthermia[J].Anesth Analg.2014,118(2):388-396.
【9】Sato H.Effect of ketamine on the Ca(2+)-related functions of skinned skeletal muscle fibers from the guinea pigs[J].Masui,1998,47(11):1296-1301.
【10】Kamitani K,Yoshida H,Arai R,et al.Case of suspected malignant hyperthermia following local infiltration anesthesia[J].Masui.2012,61(8):866-868.
【11】Beggs AE,McCann JQ,Powers JM,et al.Delayed-onset malignant hyperthermia in association with rocuronium use[J].Am J Health Syast Pharm,2012,69(13):1128-1134.
【12】何玮,曹雅鲁.氟哌啶醇致恶性高热1例[J].暨南大学学报,2004,25(2):128.
【13】李广田.氯氮平引起的恶性高热6例[J].中华临床医药杂志,2003,61(1):152-153.
【14】Antonella Carsana.Exercise-induced rhabdomyolysis and stress-induced malignant hyperthermia events, association with malignant hyperthermia susceptibility, and RYR1 gene sequence variations[J].Scientific World Journal,2013,2013:531465.
【15】Larach MG,Allen GC,Rosenberg H.Confirmation of nonanesthetic-induced malignant hyperthermia[J].Anesthesiology.2012,116(6):1398-1399.
【16】Jerry H. Kim MD.Exome Sequencing Reveals Novel Rare Variants in the Ryanodine Receptor and Calcium Channel Genes in Malignant Hyperthermia Families[J].Anesthesiology,2013,119(5):1054-1065.
【17】王颖林,郭向阳,徐仲煌等.中国人恶性高热嘉熙蓝尼定受体-1基因的筛查[J].中华麻醉学杂志,2008,28(11):1001-1003.
【18】Monnier N, Krivosic-Horber R, Payen JF, et al.Presence of two different genetic traits in malignant hyperthermia families:implication for genetic analysis,diagnosis, and incidence of malignant hyperthermia susceptibility[J].Anesthesiology. 2002,97:1067-1074.
【19】Henry Rosenberg,Henrik Rueffert.Clinical utility gene card for: malignant hyperthermia[J].European Journal of Human Genetics,2011,19(6).
【20】Werner Klingler,Sebastian Heiderich,Thierry Girard.Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study[J].Orphanet Journal of Rare Diseases,2014,9:8.
【21】O. Bandschapp,T. Girard,Malignant hyperthermia[J].Swiss Medical Weekly,2012,142:13652.
【22】Krause T,Gerbershagen MU,Fiege M,et al.Dantrolene:a review of its pharmacology,therapeutic use and new developments[J].Anaesthasia,2004,59:364-373.
【23】Shudong Fang,Hui Xu,Yesen Zhu,et al.Continuous Veno-Venous Hemofiltration for Massive Rhabdomyolysis After Malignant Hyperthermia: Report of 2 Cases[J].Anesth Prog,2013,60:21-24.
【24】Cindy L. Cain,Matthias L. Riess,Gettrust Lynn,et al.Malignant Hyperthermia Crisis: Optimizing Patient Outcomes through Simulation and Interdisciplinary Collaboration.AORN J,2014,99(2):301-311. |